|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, MYB, Deletion 6q23, TC
Test CodeCPT Codes
88271, 88275<br>Restricted Client Code - Tech Only
Preferred Specimen
Minimum Volume
Other Acceptable Specimens
Instructions
Clinical history and reason for referral are required with test order. Prior therapy and transplant history should be provided with test order.
Specimen viability decreases during transit. Send specimen to testing laboratory for viability determination. Do not freeze. Do not reject.
Transport Temperature
Specimen Stability
Methodology
Fluorescence in situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Clinical Significance
100-300 interphase cells are microscopically analyzed for probe signal patterns, indicating the copy number for the MYB region of chromosome 6q23.
Chromosome 6q deletion is a frequent abnormality in lymphoid malignancies, including acute lymphoblastic leukemia, chronic lymphoid disorders, non-Hodgkin lymphoma, and multiple myeloma. It may be the sole clonal abnormality in as many as 30% of cases. Deletions may be small and difficult to resolve, using conventional chromosome analysis. Deletion of MYB may be associated with loss of a recessive tumor suppressor gene and may be an initial step in leukemogenesis.